Dequadin

País: Malta

Idioma: anglès

Font: Medicines Authority

ingredients actius:

DEQUALINIUM CHLORIDE

Disponible des:

Reckitt Benckiser Healthcare International Limited Thane Road, Nottingham NG90 2DB, United Kingdom

Codi ATC:

R02AA02

Designació comuna internacional (DCI):

DEQUALINIUM CHLORIDE 0.25 mg

formulario farmacéutico:

LOZENGE

Composición:

DEQUALINIUM CHLORIDE 0.25 mg

tipo de receta:

OTC

Área terapéutica:

THROAT PREPARATIONS

Estat d'Autorització:

Withdrawn

Data d'autorització:

2008-07-07

Informació per a l'usuari

-------------------------
DOCUMENT OUTLINE * m1-3-1-label-revised.pdf [/PIL_MA190_00101.html#1] * Pages from RB002337-20s-UK-rv2.pdf [/PIL_MA190_00101.html#1] * m1-3-1-label-revised.pdf * foil.pdf [/PIL_MA190_00101.html#4] * dequadin 40s.pdf [/PIL_MA190_00101.html#3]

Fitxa tècnica

Page 1 of 3 
SUMMARY OF PRODUCT CHARACTERISTICS 

1. 
TRADE NAME OF THE MEDICINAL PRODUCT 

Dequadin 

2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 

Each lozenge contains 0.25 mg dequalinium chloride BP 

3. PHARMACEUTICAL 
FORM 

Lozenge 

4. CLINICAL 
PARTICULARS 

4.1 THERAPEUTIC 
INDICATIONS 

For the local therapy of most of the common infections of the
mouth 
including: Vincents angina, pharyngitis, sore throats, tonsillitis,
stomatitis, 
aphthous ulcers, thrush, glossitis. 

4.2 
POSOLOGY AND METHOD OF ADMINISTRATION 

For oral administration. 

Adults and children over 10 years: One lozenge to be sucked every 2
to 3 
hours, up to a maximum of eight in one day. 

Elderly 
There is no need for a dosage reduction in the elderly. 

4.3 CONTRAINDICATIONS 

Hypersensitivity to any of the ingredients. 

4.4 
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE 

The label states: 
Keep all medicines out of the reach of children.
If symptoms persist, consult 
your doctor. 
Warning: Do not exceed the stated dose. 

4.5 
INTERACTION WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION 

No clinically significant drug interactions known. 
Page 2 of 3 

4.6 
PREGNANCY AND LACTATION 

The safety of Dequadin during pregnancy and lactation has not been 
established, but it is not considered to constitute a hazard. 

4.7 
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES 

No adverse effects known. 

4.8 UNDESIRABLE 
EFFECTS 

Occasional hypersensitivity reactions and soreness of the tongue are
possible. 

4.9 OVERDOSE 

Overdosage should not present a problem other than
gastrointestinal 
discomfort. Treatment should be symptomatic. 

5. PHARMACOLOGICAL 
PARTICULARS 

5.1 PHARMACODYNAMIC 
PROPERTIES 

Dequalinium chloride is a quaternary ammonium antiseptic
active against 
many gram-positive and gram-negative bacteria, yeasts and fungi. 

5.2 PHARMACOKINETI